首页> Nature> An ID2-dependent mechanism for VHL inactivation in cancer.

An ID2-dependent mechanism for VHL inactivation in cancer.

导出 OA

翻译打印收藏纠错

第一作者： Sang Bae,Lee

第一单位： Institute for Cancer Genetics, Columbia University Medical Center, New York 10032, USA.

作者： Sang Bae,Lee ^[1] ; Veronique,Frattini ^[1] ; Mukesh,Bansal ^[2] ; Angelica M,Castano ^[1] ; Dan,Sherman ^[3] ; Keino,Hutchinson ^[3] ; Jeffrey N,Bruce ^[4] ; Andrea,Califano ^[2] ; Guangchao,Liu ^[1] ; Timothy,Cardozo ^[3] ; Antonio,Iavarone ^[5] ; Anna,Lasorella ^[6]

作者单位： Institute for Cancer Genetics, Columbia University Medical Center, New York 10032, USA. ^[1] Department of Systems Biology, Columbia University Medical Center, New York 10032, USA.;Center for Computational Biology and Bioinformatics, Columbia University Medical Center, New York 10032, USA. ^[2] Department of Biochemistry and Molecular Pharmacology, NYU School of Medicine, New York 10014, USA. ^[3] Department of Neurosurgery, Columbia University Medical Center, New York 10032, USA. ^[4] Institute for Cancer Genetics, Columbia University Medical Center, New York 10032, USA.;Department of Neurology, Columbia University Medical Center, New York 10032, USA.;Department of Pathology, Columbia University Medical Center, New York 10032, USA. ^[5] Institute for Cancer Genetics, Columbia University Medical Center, New York 10032, USA.;Department of Pathology, Columbia University Medical Center, New York 10032, USA.;Department of Pediatrics, Columbia University Medical Center, New York 10032, USA. ^[6]